January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreOctober 10, 2025
Projections indicate that, the global Latin America life science market will increase from USD 4.49 billion in 2024 to USD 12.05 billion by 2034, experiencing a CAGR of 10.38% over the next 10 years. The market is expanding rapidly due to rising R&D investments, technological advancements, and growing demand for precision medicine and diagnosti...
October 10, 2025
According to market projections, the new chemical entities (NCE) CDMO sector is expected to grow from USD 2.65 billion in 2024 to USD 7.83 billion by 2034, reflecting a CAGR of 11.44%. The new chemical entities (NCE) CDMO market is growing due to its offering hope for managing diseases where existing therapies fall short or are inaccessible. North ...
October 10, 2025
Market insights predict the global Latin America pharmaceutical industry will increase from USD 91.85 billion in 2024 to USD 172.71 billion by 2034, achieving a CAGR of 6.52%. The market is expanding due to the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing demand for innovative therapies. In Latin America, Br...
October 10, 2025
According to forecasts, the global myasthenia gravis treatment market will grow from USD 1.55 billion in 2024 to USD 3.29 billion by 2034, with an expected CAGR of 7.84%. The myasthenia gravis treatment market is growing due to the rising prevalence of myasthenia gravis (MG), the growing aging population, and enhanced diagnostic abilities. North Am...
October 09, 2025
According to market projections, the global hematology analyzers market, valued at USD 4.08 billion in 2024, is anticipated to reach USD 7.28 billion by 2034, growing at a CAGR of 5.97% over the next decade. Majorly impacting factors like rising prevalence of blood disorders such as anaemia, thalassemia, leukemia, and progressing innovations in pha...
October 09, 2025
Projections indicate that, Middle East & Africa behavioral health industry is projected to rise from USD 5.2 billion in 2024 to USD 9.99 billion by 2034, reflecting a CAGR of 6.75% over the next decade. The rising prevalence of mental health disorders and technological advancements drive the market. GCC countries dominated due to the increasing...
October 09, 2025
Market insights predict, the Latin America cell and gene therapy industry is expected to grow from USD 1.15 billion in 2024 to USD 10.19 billion by 2034, driven by a CAGR of 24.40%. The rising prevalence of chronic and genetic diseases is expected to drive the growth of the market....
October 09, 2025
According to market projections, the global APAC central lab market, valued at USD 622 million in 2024, is anticipated to reach USD 1085 million by 2034, growing at a CAGR of 5.72% over the next decade. The market is expanding as pharmaceutical and biotech companies increasingly rely on specialized labs for accurate, efficient, and standardized tes...
October 08, 2025
Projections indicate that, the global generative AI in drug discovery market will increase from USD 250 million in 2024 to USD 2847.43 million by 2034, experiencing a CAGR of 27.42% over the next 10 years. The generative AI in drug discovery market is growing rapidly due to technological advancements and rising government initiatives to develop nov...
October 08, 2025
Based on market forecasts, the mRNA therapeutics CDMO sector will expand from USD 4.62 billion in 2024 to USD 13.63 billion by 2034, experiencing a CAGR of 11.37%.The growing demand for vaccines and the rising prevalence of chronic disorders drive the market. The availability of state-of-the-art research and development facilities and increasing go...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com